Monday, August 23, 2021 5:50:28 PM
Spare us the ill-considered moralizing and false equivalence. Generic opioids are the mainstay of acute pain control in modern medicine. Drugs like generic Percocet and Norco are routinely and safely prescribed on daily basis around the world. If every pharmaceutical CEO had the same ethical judgement as Nasrat Hakim, then there would be frequent shortages of medications to control cancer pain, trauma pain, post-op pain, etc. There would be widespread, uncontrolled pain and suffering, and for what reason? What would be accomplished? The vast majority of opioid overdose deaths are due to illicitly-manufactured fentanyl and have nothing to do with prescription opioids. How is causing regular shortages in prescription pain medicine going to fix that?
We should not treat it lightly when we try to impose our moral beliefs on the health and well-being of someone else. I do it every day, when there is a well-considered, evidence-based reason. Get the vaccine. Don't drink and drive. Don't engage in risky sexual behavior. But I absolutely believe that denying someone adequate pain control at the end of their life because the Sacklers are bad people is a really, really gross idea. Screw the Sacklers and screw everyone else who tries to get in the way of appropriate end-of-life care.
I don't remember reading any of this moralizing about opioid risks back in 2016 when the ANDA applications were submitted. What changed? You can't have it both ways. Either it was a terrible decision in 2016 when the company committed millions of dollars and multiple years of development to generic opioids, or it was a terrible decision in 2019 when they were sold for pennies on the dollar. I favor the latter, but either way, a terrible decision was made by Nasrat Hakim. To this day the shareholders continue to suffer the long-term effects of his ill-considered moralizing and poor strategic decision-making.
#FreeSequestOx
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM